Orezone Reports 2023 Year-end and Q4 Results, and Provides 2024 Guidance
March 26, 2024 18:44 ET
|
Orezone Gold Corporation
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the...
Wilhelmina International, Inc. Announces Fourth Quarter and Full Year 2023 Results
March 26, 2024 16:30 ET
|
Wilhelmina International, Inc.
Annual Financial Highlights Annual revenues of $17.2 million for 2023.Annual operating income of $0.7 million in 2023.Annual net cash flows provided by operating activities were $0.7 million in...
Actelis Networks Reports Fiscal Full Year 2023 Results
March 26, 2024 16:30 ET
|
Actelis Networks, Inc.
FREMONT, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, hybrid-fiber rapid deployment networking...
U.S. Energy Corp. Reports Financial and Operating Results for Full Year and Fourth Quarter 2023
March 26, 2024 16:30 ET
|
U.S. Energy Corp.
HOUSTON, March 26, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality...
Logan Ridge Finance Corporation Announces Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024 16:15 ET
|
Logan Ridge Finance Corporation
Reports Strong 2023 Results with Net Investment Income of $1.43 Per Share, Compared to a Net Investment Loss of $0.43 Per Share for Year Ended 2022; Total Investment Income Increased to $20.2 Million...
Progress Announces First Quarter 2024 Financial Results
March 26, 2024 16:15 ET
|
Progress Software Corporation
Progress announces financial results in its first quarter of 2024.
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
March 26, 2024 16:10 ET
|
Panbela Therapeutics, Inc.
MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet...
ATA Creativity Global Reports 2023 Fourth Quarter and Year-end Financial Results
March 26, 2024 16:05 ET
|
ATA Creativity Global
BEIJING, China, March 26, 2024 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning...
Concentrix Reports First Quarter 2024 Results
March 26, 2024 16:05 ET
|
Concentrix Corporation
Revenue at high end of guidance rangeWell-positioned for Q2 with a strong pipelineConfirming full year business outlook for revenue, profit, cash flowCommitted to share repurchases of $100 million...
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
March 26, 2024 16:05 ET
|
Annexon Biosciences
Pivotal Phase 3 Data for ANX005 in Guillain-Barré Syndrome (GBS) Expected in Second Quarter 2024 Initiation of Pivotal Phase 3 ANX007 ARCHER II Trial in Geographic Atrophy (GA) Expected in mid-2024,...